BioAscent

Private

United KingdomHealthcare & Life Scienceshttps://www.bioascent.com/

Last Round

VC Round

Jun 25, 2018

Company Overview

BioAscent is a drug discovery company that provides integrated services including de novo assay development, compound screening, medicinal chemistry, and compound management.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

contract research organizationCROintegrated drug discoverydrug discovery servicesoutsourced drug discoverymedicinal chemistrycompound managementdiscovery biologycomputational chemistrypreclinical servicesAI drug discoveryassay developmentscreening servicescompound librarydrug metabolism and pharmacokineticsDMPK

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioAscent Comparables

Compare BioAscent with similar companies based on industry and business-model similarity.

BioAscent comparables — related companies by embedding similarity
Company	Similarity	Market Cap
SpiroChem	86%
Domainex Ltd	86%
NovAliX	85%

View all Comparables

BioAscent Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Jun 25, 2018

View all Funding Rounds

Key People

Founding team and executive leadership

Sylviane Boucharens

Chief Operating Officer And Co-founder

Founding Team

FRSB Paul Smith

CEO

Executive Team

BioAscent Investors

Notable investors and investment history

BioAscent investors
Investor	Rounds
Maven Capital Partners	VC Round

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 19, 2026
Monthly visitors grew 95% MoM.
May 2, 2025
Monthly visitors increased 31% MoM, reaching 2.1K.

View all signals

BioAscent Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

BioAscent Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BioAscent's valuation, stock price, and market status.

Firmographic Details

HeadquartersUnited Kingdom

Employee Range74

Year Founded2013

Last FundingJun 25, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.